000			01179 a2200301 4500
005			20250512045302.0
264		0	_c19880212
008			198802s 0 0 eng d
022			_a0091-2700
024	7		_a10.1002/j.1552-4604.1987.tb03031.x _2doi
040			_aNLM _beng _cNLM
100	1		_aFuks, J Z
245	0	0	_aPhase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protection. _h[electronic resource]
260			_bJournal of clinical pharmacology _c
300			_a357-65 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aCarboplatin
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aDrug Evaluation
650	0	4	_aHumans
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aOrganoplatinum Compounds _xtherapeutic use
650	0	4	_aThiosulfates _xtherapeutic use
700	1		_aWadler, S
700	1		_aWiernik, P H
773	0		_tJournal of clinical pharmacology _gvol. 27 _gno. 5 _gp. 357-65
856	4	0	_uhttps://doi.org/10.1002/j.1552-4604.1987.tb03031.x _zAvailable from publisher's website
999			_c3325859 _d3325859